|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1350 AUD | -6.90% |
|
-6.90% | -10.00% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 69.3 | - |
| Change | - | - | 343.99% | -42.53% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 53.8 | 47.8 |
| Change | - | - | 241.42% | -41.98% | -11.15% |
| P/E | -2.64x | -3.27x | -14.3x | -5.87x | -22.5x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 6.93x |
| EV / Revenue | - | - | - | - | 4.78x |
| EV / EBITDA | - | - | -11.2x | -4.68x | -13.7x |
| EV / EBIT | - | - | -11.1x | -4.64x | -13.3x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1350 | 0.1350 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 5/30/23 A | 5/30/25 A | 5/29/26 A | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.87x | - | -4.68x | - | 48.39M | |
| 19.5x | 6.01x | 13.15x | 1.63% | 52.1B | |
| 32.22x | 8.13x | 25.24x | 0.05% | 53.83B | |
| -42.48x | 13.5x | -39.59x | -.--% | 23.48B | |
| -18.22x | 4.32x | -7.57x | -.--% | 23.13B | |
| 24.24x | 4.75x | 12.54x | -.--% | 19.36B | |
| 24.39x | 4.78x | 15.56x | -.--% | 17.56B | |
| 45.88x | 18.59x | 47.88x | 0.08% | 15.2B | |
| -505.73x | 35.47x | -1462.84x | -.--% | 14.83B | |
| 17.57x | 5.11x | 11.88x | -.--% | 14.06B | |
| Average | -40.85x | 11.19x | -138.84x | 0.2% | 23.36B | |
| Weighted average by Cap. | -18.52x | 9.52x | -82.80x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
